Health Trials

Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

1

Review clinical trials related to Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

The study evaluated the overall survival (OS) of SHR-A1904 versus investigator-selected treatment in second-line CLDN18.2-positive advanced GC/GEJC patients

Participants needed: 524
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.Updated: May 15, 2026Locations: 1
Eligibility criteria

Age 18 to 75 years old (including boundary values) [+7]

Received anti-tumor therapies such as chemotherapy, radiotherapy, biological the... [+6]

Read more